Opendata, web and dolomites

ToCCaTa SIGNED

Tailoring the functional Capacity of Cytotoxic T cells for future Therapies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ToCCaTa project word cloud

Explore the words cloud of the ToCCaTa project. It provides you a very rough idea of what is the project "ToCCaTa" about.

mechanisms    liver    limited    supporting    infections    cell    functional    mimic    enormous    augment    cytotoxic    screening    contrasting    translate    systematic    vaccine    particularities    seek    interventional    attenuate    therapeutic    hypothesis    treating    immunotherapy    alter    molecular    malignant    functions    protection    safe    fulfil    performing    anti    overcome    cells    significantly    expression    anticipate    cd8    advantage    gene    tumor    immunity    lung    induction    obstacle    autoimmunity    single    equally    equipped    fulminant    disease    viral    function    chronic    diversity    memory    pleiotropic    hypo    resting    of    resident    optimize    proliferative    instance    immunopathology    aggressive    foundation    effector    qualitative    generation    stage    solutions    immunotherapies    acute    tissue    tumors    utilizing    experimental    capacity    pathogen    interventions    exhausted    adjusted    strategies    prophylactic    comprehension    combination    phenotypes    similarly    diseases    discovery    activated    vital    customized    thought    optimized   

Project "ToCCaTa" data sheet

The following table provides information about the project.

Coordinator
TECHNISCHE UNIVERSITAET MUENCHEN 

Organization address
address: Arcisstrasse 21
city: MUENCHEN
postcode: 80333
website: www.tu-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙999˙850 €
 EC max contribution 1˙999˙850 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-COG
 Funding Scheme ERC-COG
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2023-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNISCHE UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙999˙850.00

Map

 Project objective

Cytotoxic T cells have enormous potential for prophylactic and therapeutic interventions against problematic acute or chronic infections and against malignant tumors. A major obstacle to utilizing them effectively is our limited understanding of the molecular foundation that is necessary for CD8 T cells to fulfil their pleiotropic functions. Equally important is to find solutions supporting the robust and safe induction of large numbers of pathogen- or tumor-specific T cells and strategies for customized generation of T cells equipped with a functional capacity that are optimized to the often contrasting needs of particular diseases. For instance, anti-tumor immunity requires large numbers of highly activated effector T cells, while resting memory cells with high proliferative potential in combination with tissue-resident memory cells are thought to enhance protection against viral infections. Similarly, the challenge in treating chronic infections and tumors is to overcome the hypo-functional “exhausted” stage of T cells, but therapeutic induction of the same mechanisms to attenuate an aggressive T cell response could be vital for treating autoimmunity or immunopathology in fulminant liver or lung infections. Thus, to develop prophylactic or interventional strategies through which qualitative aspects of T cell function can be adjusted is a current key challenge in the immunotherapy and vaccine field. We seek to promote such activities by performing research that aims to significantly augment our comprehension of how molecular particularities translate into functional diversity. By taking advantage of 1) experimental systems that specifically mimic disease relevant T cell phenotypes, 2) approaches to assess molecular diversity at single cell level, 3) effective strategies to alter gene expression, and 4) systematic and hypothesis-driven molecular screening, we anticipate the discovery of new targets to optimize immunotherapies for tumors and chronic infections.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TOCCATA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TOCCATA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

LO-KMOF (2019)

Vapour-deposited metal-organic frameworks as high-performance gap-filling dielectrics for nanoelectronics

Read More  

CURVE-X (2019)

Industrialisation of curved sensors and related imagers

Read More  

PLAT_ACE (2019)

A new platform technology for the on-demand access to large acenes

Read More